According to Coherent Market Insights, the global clinical trial management system market size is calculated at 2.10 billion in 2024 and is projected to surpass USD 5.55 billion by 2031 with a remarkable CAGR of 14.9% from 2024 to 2031.
The growth of the clinical trial management systems market is attributed to the increasing R&D investments in pharmaceutical and biotechnology industries and rising complexity in clinical trials. Pharmaceutical companies are investing highly in R&D to develop novel drug candidates. These investments are expected to boost the demand for clinical trial management systems to streamline clinical trials.
The Complete Study is Now Available for Immediate Access | Request the Sample Pages of this Report@ https://www.coherentmarketinsights.com/insight/request-sample/212
Moreover, clinical trials have become complex over the years with involvement of many sites, high patient volume, and strict regulatory guidelines, thereby necessitating adoption of clinical trial management systems.
Market Trends:
Integration of advanced technologies like artificial intelligence and analytics is a key trend gaining traction in clinical trial management systems. Vendors are integrating AI and analytics into their software solutions to provide enhanced features like patient recruitment and retention, protocol design, risk-based monitoring, and post marketing analysis.
Medidata offers an AI powered patient recruitment solution. This helps accelerate patient enrollment by predicting enrollment feasibility. Furthermore, adoption of cloud-based clinical trial management systems is increasing owing to advantages such as easy deployment, scalability, and lower costs. This has encouraged several vendors to offer cloud-based CTMS solutions.
Clinical Trial Management System Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2024 |
$2.10 billion |
|
Estimated Value by 2031 |
$5.55 billion |
|
Growth Rate |
Poised to grow at a CAGR of 14.9% |
|
Historical Data |
2019–2023 |
|
Forecast Period |
2024–2031 |
|
Forecast Units |
Value (USD Million/Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
By Mode of Delivery, By Component, By End User |
|
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of World |
|
Growth Drivers |
• Increasing innovative technological advancements • Rising demand for improved data capture and management |
|
Restraints & Challenges |
• High installation and maintenance costs • Lack of interoperability standards for CTMS |
Market Opportunities:
Clinical data management is anticipated to be the largest segment during the forecast period. Clinical data management solutions help in digitizing and streamlining clinical trial data across sites, functions, and systems. They enable clinical research teams to effectively collect, clean, track, and report clinical trial data in real-time. Moreover, clinical data management solutions enhance data quality control, data consistency, and regulatory compliance.
Immediate Delivery Available | Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/212
Patient recruitment and retention solutions are expected to grow at the fastest rate over the next few years. These solutions help pharmaceutical companies and CROs in identifying eligible patients for clinical trials, obtaining informed consent, and retaining patients throughout the study duration. They provide digital tools to streamline patient engagement and improve efficiency.
Key Market Takeaways
Clinical trial management systems market is anticipated to witness a CAGR of 14.9% during the forecast period 2024-2031. This is owing to increasing R&D expenditure of pharmaceutical companies and rising number of clinical trials.
On the basis of component, software segment is expected to hold a dominant position, owing to increasing adoption of software-as-a-service delivery model. Cloud-based CTMS segment is projected to grow at the fastest rate during the forecast period due to benefits such as scalability, flexibility, and low maintenance costs.
On the basis of end user, pharmaceutical and biotechnology firms segment is expected to hold the largest market share in 2024. This segment is expected to remain dominant over the forecast period. Growing clinical research activities by big pharmaceutical players are driving the demand for CTMS solutions.
Regionally, North America is anticipated to dominate the clinical trial management systems market during the forecast period. Presence of majority global CTMS vendors and high clinical research budget of the U.S. are contributing to the largest share of the region.
Competitor Insights
- Advarra Inc.
- ArisGlobal LLC
- BioClinica Inc.
- DataTrak International Inc.
- DSG Inc.
- ERT Clinical
- Medidata Solutions Inc.
Recent Developments:
In June 2022, Medidata Solutions (US), a Dassault Systèmes company, announced technological improvements to solve challenges in clinical trial management. It will improve data oversight and reporting for contract research organizations (CROs) and sponsors
In March 2020, Medidata Solutions (US) launched a new program to support research organizations conducting any type of immunology-related research, including clinical studies on COVID-19 vaccines, diagnostics, and treatments.
Ask For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/212
Detailed Segmentation-
By Mode of Delivery
- Cloud-based
- On-premise
By Component
- Software
- Services
By End User
- Healthcare Companies
- Biopharmaceutical companies
- Clinical Research Organization
- Academic & Research Institutes
- Others
By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Find Most Trending Related Report:
The global oncology information systems market size is expected to reach US$ 13.85 Bn by 2030, from US$ 8.19 Bn in 2023, at a CAGR of 7.8% during the forecast period.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-650-918-5898
UK: +44-020-8133-4027
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
